Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
about
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trialCobalamin deficiency, hyperhomocysteinemia, and dementiaA strategy to reduce cardiovascular disease by more than 80%Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementationRisk factors in coronary atherosclerosis athero-inflammation: the meeting pointIs type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stressEffect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans.Effect of folic acid and betaine supplementation on flow-mediated dilation: a randomized, controlled study in healthy volunteersAcute effect of folic acid, betaine, and serine supplements on flow-mediated dilation after methionine loading: a randomized trial.Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease.Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain productsThe rationale for targeting the NAD/NADH cofactor binding site of parasitic S-adenosyl-L-homocysteine hydrolase for the design of anti-parasitic drugs.Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years.Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.Micronutrients: dietary intake v. supplement use.The status of vitamin B12 and folate among Chinese women: a population-based cross-sectional study in northwest China.Folate in colorectal cancer, prostate cancer and cardiovascular disease.Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.Inertia on folic acid fortification: public health malpractice.Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin.Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasmEating well: ageing gracefully!Recent trends in lipid management: raising the bar and shifting the goalposts?Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence.Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.Does homocysteine cause hypertension?Thrombophilia and stroke.The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells.Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndromeHyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?Dietary choline and betaine intakes and risk of cardiovascular diseases: review of epidemiological evidence.Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young IndiansThe drug-based pipeline against restenosis.Intracoronary radiation therapy: an evidence-based analysis.B-vitamins, homocysteine metabolism and CVD.
P2860
Q22066036-063311E7-5426-4DBF-9FC6-0A53C0D4B352Q24606994-15502921-DFCD-40F4-9AC8-6460458252B8Q24609123-4F76FC71-CA55-4A37-B039-8BA5974BC89DQ24679592-52E9C1D2-3B86-4630-923C-9A5C73D699B0Q24791545-A5C7D48F-D2A4-41B2-B8B8-72DF29F8B7D3Q24793107-7E462E22-8BEF-40CE-B734-4C4C976D45C8Q24805294-77D3FB2C-FD25-4525-83F4-84E911AFCACAQ24810064-8AE766AF-E0EB-4510-A11A-1BBC521BCFF5Q28469018-E80815B3-DDC9-4105-91BD-D9C8AB13C17AQ33251911-746F460E-EC87-4B1E-9886-7A515ED89852Q33915599-BCB17AB3-76A8-448D-93CD-3BC7EA4CF678Q33940846-CA0E8D51-BB38-4BA0-90A3-F4B0A175A895Q34024913-D67C255B-1ABD-4285-AC61-6A3D5CC9CF01Q34141490-6C2AB6B0-53A1-4CD6-A9CA-D0F56C15A275Q34160359-F71BB673-B72E-4765-AEBF-17665853F645Q34356824-907893CA-90EC-47A5-96AA-4E2DB6261E77Q34470904-730987CD-C5E2-454E-9246-6CDDB915F1C7Q34497850-23720073-1B79-4CF3-8AD9-C5F91D9321D5Q34582313-A82039A2-980D-4BD7-942B-ED631EB6433CQ34591566-EF25C5DB-AFED-4E5C-BBA1-F96E8EB5C466Q34736750-3F8672D5-56A3-4EDD-B9C7-558D05142FDDQ34773911-1D94D070-FA60-4E1B-992B-F8270F213627Q35022284-A8BA651B-1E53-4A94-80A2-CF32CBFF8593Q35030776-6F3C0627-636B-40FC-BB36-E1914B8B0E88Q35072212-99C366D7-72DB-4AE2-9AEB-B59B51F5755BQ35160971-E76AF3DF-82CC-4737-9000-178834A21F65Q35583124-C364328B-A3B0-42B6-8994-02D34F64D6C6Q35600410-8D0C980A-BD06-48E2-B79D-9B650DDDEE21Q35600418-5C5B65C8-3018-4025-9A2D-1C71A706A76BQ35610110-E3FB7FD8-3FF5-498D-8576-A7C62AE39180Q35684825-516234C3-B488-462C-AB7A-8E78F9096376Q35690674-A0577EFB-CBEC-454D-975C-63B51923F5AFQ35773198-1424FF1D-4517-4E93-9F88-69D629A9D4EFQ35925719-387CE1DE-C457-480C-B35C-21159F5FB5A8Q35945281-E4A51A76-90F6-4C18-98E7-6107AC1947DBQ36013120-D2FBACED-3496-49A0-A6BA-59FA2C88F5D7Q36064298-1AEE7D83-7D09-41C0-8B77-3972D05BB20DQ36066019-6587DF23-4F2B-4628-958C-33364A4B1F30Q36070778-6ABBE710-14F0-4B89-BF48-ED8FB95114B1Q36098211-0C9A41C5-3377-4A9B-849E-B097BDD59F5E
P2860
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
@en
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
@nl
type
label
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
@en
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
@nl
prefLabel
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
@en
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
@nl
P2093
P356
P1476
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
@en
P2093
Schnyder G
P304
P356
10.1056/NEJMOA011364
P407
P577
2001-11-01T00:00:00Z